Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-22-003539
Filing Date
2022-05-16
Accepted
2022-05-16 17:12:50
Documents
60
Period of Report
2022-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q thct_10q.htm   iXBRL 10-Q 883361
2 CERTIFICATION thct_ex311.htm EX-31.1 9272
3 CERTIFICATION thct_ex312.htm EX-31.2 9034
4 CERTIFICATION thct_ex321.htm EX-32.1 3516
5 CERTIFICATION thct_ex322.htm EX-32.2 4248
  Complete submission text file 0001477932-22-003539.txt   3840259

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA thct-20220131.xsd EX-101.SCH 45440
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE thct-20220131_lab.xml EX-101.LAB 223462
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thct-20220131_cal.xml EX-101.CAL 40007
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thct-20220131_pre.xml EX-101.PRE 195631
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE thct-20220131_def.xml EX-101.DEF 122105
54 EXTRACTED XBRL INSTANCE DOCUMENT thct_10q_htm.xml XML 536537
Mailing Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135
Business Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135 833-420-8428
THC Therapeutics, Inc. (Filer) CIK: 0001404935 (see all company filings)

EIN.: 260164981 | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-55994 | Film No.: 22930823
SIC: 3523 Farm Machinery & Equipment